No persistent T lymphocyte immunosuppression or increased mortality after measles infection: A community study from Guinea-Bissau

Pediatric Infectious Disease Journal

Volumn 15, Issue 1, 1996, Pages 39-44

  Aaby, Peter ^a,d   Lisse, Ida M ^b   Mølbak, Kåre ^a   Knudsen, Kim ^a   Whittle, Hilton ^c  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d Epidemiology Research Unit   (Denmark)

Author keywords

Childhood mortality; immunosuppression; measles; measles immunization; postmeasles mortality; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MEASLES VACCINE;

AFRICA; ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; FEMALE; GUINEA-BISSAU; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; MALE; MEASLES; T-LYMPHOCYTES;

EID: 0030053686     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199601000-00009     Document Type: Article

References (32)

1. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984;8:13-21.
2. Hull HF, Williams PJ, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983;1;972-5.
3. Aaby P, Clements J. Measles immunization research: a review. Bull World Health Organ 1989;67:443-8.
4. Shahid NS, Clauquin P, Shaikh K, Zimicki S. Long-term complications of measles in rural Bangladesh. J Trop Med Hyg 1983;86:77-80.
5. Bhaskaram P, Reddy V, Raj S, Bhatnager RC. Effect of measles on the nutritional status of preschool children. J Trop Med Hyg 1984;87:21-5.
6. Aaby P. Determinants of measles mortality: host or transmission factors? In: de la Maza LM, Peterson EM, eds. Medical virology, vol 10. New York: Plenum, 1991:83-116.
7. Clemens JD, Stanton BF, Chakraborty J. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemior 1988;128:1330-9.
8. Garenne M, Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis 1990;161:1088-94.
9. Aaby P, Knudsen K, Whittle H. Long-term survival after Edmonston-Zagreb measles vaccination: increased female mortality. J Pediatr 1993;122:904-8.
10. Aaby P, Samb B, Simondon F. Sex specific mortality after high titre measles vaccines in rural Senegal. Bull World Health Organ 1994;72:761-70.
11. Halsey N. Increased mortality following high titer measles vaccines: too much of a good thing. Pediatr Infect Dis J 1993;12:462-5.
12. Lisse IM, Whittle H, Aaby P, Normark M, Gyhrs A, Ryder LP. Labelling of T-cell subsets under field conditions in tropical countries: adaptation of the immuno-alkaline phosphatase staining method for blood-smears. J Immunol Methods 1990;129:49-53.
13. Lisse IM, Aaby P, Whittle H, Knudsen K, Andersen H. Long-term impact of high-titre Edmonston-Zagreb measles vaccine on T-cell subsets. Pediatr Infect Dis J 1994;13:109-12.
14. Mølbak K, Højlyng N, Gottschau A. Cryptosporidiosis in infancy and childhood mortality in Guinea-Bissau, West Africa. Br Med J 1993;307:417-20.
15. Whittle HC, Campbell H, Rahman S, Armstrong JRM. Antibody persistence in Gambian children after high-dose Ed-monston-Zagreb measles vaccine. Lancet 1990;336:1046-8.
16. Holt JD, Prentice RL. Survival analyses in twin studies and matched pair experiments. Biometrika 1974;61,1:17-30.
17. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
18. Kiepiela P, Coovadia HM, Coward P. T helper cell defect related to severity of measles. Scand J Infect Dis 1987;19:185-92.
19. Dagan R, Phillip M, Sarov I, Epstein S, Kuperman O. Cellular immunity and T-lymphocyte subsets in young children with acute measles. J Med Virol 1987;22:175-82.
20. Arneborn P, Biberfeld G. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun 1983;39:29-37.
21. Aaby P, Samb B, Andersen M, Simondon F. No long-term excess mortality after measles infection: a community study from Senegal. Am J Epidemiol (in press).
22. Chen RT, Weierbach R, Bisoffi Z, et al. A "post-honeymoon period" measles outbreak in Muyinga Sector, Burundi. Int J Epidemiol 1994;23:185-93.
23. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles mortality, state of nutrition, and family structure: a community study from Guinea-Bissau. J Infect Dis 1983;147:693-701.
24. Aaby P, Bukh J, Lisse IM, da Silva CM. Measles mortality decline: nutrition, age at infection or exposure? Br Med J 1988;296:1225-8.
25. Aaby P, Samb B, Simondon F, Coll Seek AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunization. Analysis of mortality studies from developing countries. Br Med J 1995;311:481-5.
26. Griffin DE. Immunological abnormalities accompanying acute and chronic viral infections. Rev Infect Dis 1991;13: S129-33.
27. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993;168:275-81.
28. Petralli JK, Merigan TC, Wilbur JR. Action of endogenous interferon against vaccinia infection in children. Lancet 1965;2:401-5.
29. Booth I, Sinani HM, Smedman L, Björkman A. A study of malaria infection during the acute stage of measles infection. J Trop Med Hyg 1991;94:195-8.
30. Lange PK. Morbilli and tuberculosis in Greenland. Scand J Respir Dis 1970;51:256-67.
31. Aaby P, Andersen M, Sodemann, Jakobsen M, Gomes J, Fernandas M. Reduced childhood mortality following standard measles vaccination at 4-8 months compared to 9-11 months of age. Br Med J 1993;307:1308-11.
32. Aaby P, Samb B, Simondon F. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol 1993;138:746-55.